David Schenkein - Insider Trading & Ownership

Entity
Individual
Location
C/O Bluebird Bio, Inc., 840 Memorial Drive, Cambridge, Massachusetts
Summary
The estimated net worth of David Schenkein is at least $11.4 M dollars as of June 24, 2024. David Schenkein is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $10.1 M. David Schenkein is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $973 K. David Schenkein is the Director of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $268 K.
All Insider Reports
All Insider Reports

Ownership of David Schenkein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AGIO AGIOS PHARMACEUTICALS, INC. Director $10.1 M -$4.66 M -31.5% Jun 20, 2024
DNLI Denali Therapeutics Inc. Director $973 K May 31, 2024
REGN REGENERON PHARMACEUTICALS, INC. Director $268 K Jan 2, 2024
PRME Prime Medicine, Inc. Director Jun 12, 2024

Insider Transactions Reported by David Schenkein:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership